Journal of Adolescent Health
Volume 33, Issue 5 , Pages 396-409 , November 2003

Guidelines for Adolescent Health Research: A position paper of the Society for Adolescent Medicine

References 

  1. Anonymous. Guidelines for Adolescent Health Research. J Adolesc Health 1995;17:264–9
  2. U.S. Congress, Office of Technology Assessment . Adolescent Health-Volume I (Summary and Policy Options). Washington, DC: U.S. Government Printing Office; 1991; OTA-H-468
  3. National Commission on the Role of the School and the Community in Improving Adolescent Health. Code Blue: Uniting for Healthier Youth. City, state: National Association of State Boards of Education and American Medical Association, 1991
  4. Task Force on Education of Young Adolescents. Turning Points: Preparing American Youth for the 21st Century. Washington, DC: Carnegie Council on Adolescent Development, Carnegie Corporation of New York, 1989
  5. National Commission on AIDS . Preventing HIV/AIDS in Adolescents. Washington, DC: National Commission on AIDS; 1993;
  6. National Research Council (Miller HG, Turner CF, Moses LE, editors). AIDS: The Second Decade. Washington, DC: National Academy Press, 1990
  7. Moolchan ET, Mermelstein R. Research on tobacco use among teenagers (Ethical challenges). J. Adolesc Health. 2002;30:409–417
  8. Milsap RL, Hill MR, Szefler SJ. Special pharmacokinetic considerations in children. In: Evans WE, Schentag JJ, Jusko WJ (eds). Applied Pharmacokinetics. 3rd edition. Vancouver, WA: Applied Therapeutics, 1992:***–***
  9. Rosenfeld WD, Vermund SH, Wentz SJ, Burk RD. High prevalence rate of human papillomavirus infection and association with abnormal smears in sexually active adolescents. Am J Dis Child. 1989;143:1443–1447
  10. Moscicki AB, Ellenberg JH, Vermund SH, et al.  Prevalence of and risks for cervical human papillomavirus infection and squamous intra-epithelial lesions in adolescent women (Impact of infection with human immunodeficiency virus). Arch Pediatr Adolesc Med. 2000;154:127–134
  11. Crowley-Nowick PA, Ellenberg JH, Vermund SH, et al.  Cytokine profile in genital tract secretions from female adolescents (Impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens). J Infect Dis. 2000;181:939–945
  12. Strobino DM. The health and medical consequences of adolescent sexuality and pregnancy: A review of the literature. In: Hayes CD, Hofferth SL (eds). Risking the Future: Adolescent Sexuality, Pregnancy and Childbearing: Working Papers and Statistical Appendices. Vol. II. Washington, DC: National Academy Press, 1987:888–***
  13. Korenbrot CC, Showstack J, Loomis A, Brindis C. Birth weight outcomes with case management in a teenage pregnancy program. J Adolesc Health Care. 1989;10:97–104
  14. Kirby D. Emerging Answers: Research Findings on Programs to Reduce Teen Pregnancy. Washington, DC: The National Campaign to Prevent Teen Pregnancy; 2001;
  15. DiClemente RJ. Preventing HIV/AIDS among adolescents. Schools as agents of behavior change. JAMA. 1993;270:760–762
  16. Rogers AS. A research agenda for the study of therapeutic agents in adolescents. J Adolesc Health. 1994;15:672–678
  17. Elster AB, Kuznets NJ. AMA Guidelines for Adolescent Preventive Services (GAPS): Recommendations and Rationale. Baltimore, MD: Williams and Wilkins; 1993;
  18. Wilson CM, Houser J, Partlow C, et al.  Adolescent Medicine HIV/AIDS Research Network, The REACH Project (Reaching for Excellence in Adolescent Care and Health): Study design, methods, and population profile. J Adolesc Health. 2001;29(Suppl):8–18
  19. DuRant RH, Pendergrast RA, Cadenhead C. Exposure to violence and victimization and fighting behavior by urban black adolescents. J Adolesc Health. 1994;15:311–318
  20. Levine C. Children in HIV/AIDS clinical trials (Still vulnerable after all these years). Law Med Health Care. 1991;19:231–237
  21. DuRant RH, Cadenhead C, Pendergrast RA, et al.  Factors associated with the use of violence among urban black adolescents. Am J Public Health. 1994;84:612–617
  22. Rutter M. Psychosocial resilience and protective mechanisms. Am J Orthopsychiatry. 1987;57:316–331
  23. Resnick MD, Bearman PS, Blum RW, et al.  Protecting adolescents from harm (Findings from the National Longitudinal Study of Adolescent Health). JAMA. 1997;278:823–832
  24. Rogers AS, D'Angelo L, Futterman D. Guidelines for adolescent participation in research (Current realities and possible resolutions). IRB. 1994;16:1–6
  25. Select Committee on Children, Youth, and Families, US House of Representatives . A Decade of Denial (Teens and AIDS in America). Washington, DC: U.S. Government Printing Office; 1992;
  26. Levine C, Dubler NN, Levine RJ. Building a new consensus (Ethical principles and policies for clinical research on HIV/AIDS). IRB. 1991;13:1–17
  27. Grodin MA, Alpert JJ. Children as participants in medical research. Pediatr Clin North Am. 1988;35:1389–1401
  28. Gardner W, Wilcox BL. Political intervention in scientific peer review (Research on adolescent sexual behavior). Am Psychol. 1993;48:972–983
  29. Mammel KA, Kaplan DW. Research consent by adolescent minors and institutional review boards. J Adolesc Health. 1995;17:322–329
  30. Sieber JE, Stanley B. Ethical and professional dimensions of socially sensitive research. Am Psychol. 1988;43:49–55
  31. Janofsky J, Starfield B. Assessment of risk in research on children. J Pediatr. 1981;89:842–846
  32. Rogers AS, Schwarz DF, Weissman G, English A. Adolescent participation in clinical research (Eleven sites, one common protocol, and Eleven IRBs). IRB. 1999;21:6–10
  33. Department of Health and Human Services, National Institutes of Health, Office for Protection from Research Risks. Code of Federal Regulations: Title 45-Public Welfare; Part 46: Protection of Human Subjects. November 13, 2001
  34. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: US Government Printing Office, DHEW Pub. No. (OS) 78-0012, 1978
  35. Society for Adolescent Medicine . Code of Research Ethics (A Position Paper of the Society for Adolescent Medicine). J Adolesc Health. 1999;24:277–282
  36. Bleyer WA, Tejeda H, Murphy SB, et al. National cancer clinical trials: Children have equal access; adolescents do not. J Adolesc Health 1997;366–73
  37. National Institutes of Health. NIH Policy and Guidelines On The Inclusion Of Children As Participants In Research Involving Human Subjects. March 6, 1998. Available at: http://grants1.nih.gov/grants/guide/notice-files/not98-024.html. Accessed April 10, 2003
  38. Glantz LH. The law of human experimentation with children. In:  Grodin MA,  Glantz LH editor. Children as Research Subjects (Science, Ethics, and Law). New York: Oxford University Press; 1994;p. 103–130
  39. Melton GB. Children's rights (Where are the children?). Am J Orthopsychiatry. 1982;52:530–538
  40. Holder AR. Legal issues in adolescent sexual health. Adolesc Med: STAR. 1992;3:257–268
  41. English A. Treating adolescents (Legal and ethical considerations). Med Clin North Am. 1990;74:1097–1112
  42. English A, Matthews M, Palamountain C, et al.  State Minor Consent Statutes (A summary). San Francisco: National Center for Youth Law; 1995;
  43. English A, Morreale M. A legal and policy framework for adolescent health care (Past, present, and future). Houston J Health Law Policy. 2001;1:63–108
  44. Melton GB. Ethical and legal issues in research and intervention. J Adolesc Health Care. 1989;10(3 Suppl):36S–44S
  45. English A. Adolescent reproductive health services for adolescents: Critical legal issues. Obstet Gynecol Clin North Am 2000;27195–211
  46. In:  Gans J editors. Policy Compendium on Confidential Health Services for Adolescents. Chicago: American Medical Association National Coalition on Adolescent Health; 1993;
  47. Department of Health and Human Services. Standards for Privacy of Individually Identifiable Health Information; Final Rule. 65 Fed. Reg. 82462 (2000); 67 Fed. Reg. 53182 (2002) (to be codified at 45 CFR Parts 160 and 164)
  48. Department of Health and Human Services. Protecting personal health information in research — Understanding the HIPAA Privacy Rule. Department of Health and Human Services. Washington, DC: Department of Health and Human Services, 2003
  49. Department of Health and Human Services. Standards for Privacy of Individually Identifiable Information; Final Rule, 67 Fed. Reg. 53267 (2002) (to be codified at 45 CFR 164.502(g)(3))
  50. Leikin SL. An ethical issue in biomedical research (The involvement of minors in informed and third party consent). Clin Res. 1983;31:34–40
  51. Weithorn LA. Children's capacities to decide about participation in research. IRB. 1983;5:1–5
  52. Weithorn LA, Scherer DG. Children's involvement in research participation decisions (Psychological considerations). In:  Grodin MA,  Glanz LH editor. Children as Research Subjects (Science, Ethics, and Law). New York: Oxford University Press; 1994;p. 133–179
  53. Melton GB. Toward “personhood” for adolescents. Autonomy and privacy as values in public policy. Am Psychol. 1983;38:99–103
  54. Susman EJ, Dorn LD, Fletcher JC. Participation in biomedical research: The consent process as viewed by children, adolescents, young adults, and physicians. J Pediatr 1992;547–52
  55. Peterson AC, Leffert N. Developmental issues influencing guidelines for adolescent health research. J Adolesc Health. 1995;17:298–305
  56. Thompson RA. Vulnerability in research (A developmental perspective on research risk). Child Dev. 1980;61:1–16
  57. National Bioethics Advisory Commission . Ethical and Policy Issues in Research Involving Human Participants, Volume I. Report and Recommendations of the National Bioethics Advisory Commission. Bethesda, MD: Office of the President; 2001;
  58. Levine RJ. Adolescents as research subjects without permission of their parents or guardians (Ethical considerations). J Adolesc Health. 1995;17:286–296
  59. In:  Mastrionni AC,  Faden R,  Federman D editor. Women and Health Research (Ethical and Legal Issues of Including Women in Clinical Studies, Volume I). Washington: Institute of Medicine, National Academy Press; 1994;
  60. Food and Drug Administration. The Pediatric Exclusionary Provision, January 2001 Status Report to the Congress (January 9, 2001). Website: http://www.fda.gov/cder/pediatric/reportcong01.pdf. Accessed April 10, 2003
  61. Food and Drug Administration. Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients; Final Rule. 21 CFR Parts 201, 312, 314, and 601. Website: http://www.fda.gov/ohrms/dockets/98fr/120298c.txt. Accessed April 10, 2003
  62. Shirkey HC. Therapeutic orphans. J Pediatr. 1968;72:119–120
  63. Levine RJ. Institutional review boards (A crisis in confidence). Ann Intern Med. 2001;134:161–163
  64. Melton GB, Levine RJ, Koocher GP, et al.  Community consultation in socially sensitive research. Lessons from clinical trials of treatments for AIDS. Am Psychol. 1988;43:573–581
  65. Jenkins R, Parron D. Guidelines for adolescent health research (Issues of race and class). J Adolesc Health. 1995;17:313–321
  66. Thomas SB, Quinn SC. The Tuskegee Syphilis study, 1932 to 1972 (Implications HIV education and AIDS risk education programs in the black community). Am J Public Health. 1991;81:1498–1504
  67. Lederer SE, Grodin MA. Historical overview: Pediatric experimentation. In:  Grodin MA,  Glanz LH editor. Children as Research Subjects: Science, Ethics, and Law. New York: Oxford University Press; 1994;p. 3–25
  68. Gans JE, Brindis CD. Choice of research setting in understanding adolescent health problems. J Adolesc Health. 1995;17:305–312
  69. 20 U.S.C. § 1232g; 34 C.F.R. Part 99
  70. 20 U.S.C. § 1232h; 34 C.F.R. Part 98
  71. U.S. Department of Education. Recent Changes Affecting FERPA & PPRA. October 28, 2002. Available at: http://www.ed.gov/offices/OII/fpca/pdf/ht_102802.pdf. Accessed May 6, 2003
  72. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Report and Recommendations: Research Involving Children. Washington, DC: US Government Printing Office, DHEW Pub. No. (OS) 77-0004, 1977
  73. English A. Guidelines for adolescent health research (Legal perspectives). J Adolesc Health. 1995;17:276–285
  74. Food and Drug Administration. Additional Safeguards for Children in Clinical Investigations of FDA-Regulated Products. 21 CFR Parts 50 and 56. Federal Register: April 24, 2001 (Volume 66, Number 79), Rules and Regulations, Pages 20589–600. Available at: http://www.fda.gov/OHRMS/DOCKETS/98fr/042401a.pdf. Accessed April 10, 2003
  75. National Human Research Protections Advisory Committee. Comment letter to the FDA on 45 CFR 46 408(c). August 13, 2001. Available at: http://ohrp.osophs.dhhs.gov/nhrpac/documents/fda.pdf. Accessed September 1, 2002
  76. English A, Morreale MC, Stinnett A, et al. State minor consent laws: A summary. Chapel Hill, NC: Center for Adolescent Health & the Law. (In press.)

☆ Address reprint requests to: Society for Adolescent Medicine, 1916 Copper Oaks Circle, Blue Springs, MO 64015.

☆☆ This position paper represents views of the Society for Adolescent Medicine and should not imply endorsement by any other organization.

PII: S1054-139X(03)00290-8

doi: 10.1016/j.jadohealth.2003.06.009

Journal of Adolescent Health
Volume 33, Issue 5 , Pages 396-409 , November 2003

Article Tools